Literature DB >> 16530579

Type 1 diabetes.

Denis Daneman1.   

Abstract

Type 1 diabetes accounts for only about 5-10% of all cases of diabetes; however, its incidence continues to increase worldwide and it has serious short-term and long-term implications. The disorder has a strong genetic component, inherited mainly through the HLA complex, but the factors that trigger onset of clinical disease remain largely unknown. Management of type 1 diabetes is best undertaken in the context of a multidisciplinary health team and requires continuing attention to many aspects, including insulin administration, blood glucose monitoring, meal planning, and screening for comorbid conditions and diabetes-related complications. These complications consist of microvascular and macrovascular disease, which account for the major morbidity and mortality associated with type 1 diabetes. Newer treatment approaches have facilitated improved outcomes in terms of both glycaemic control and reduced risks for development of complications. Nonetheless, major challenges remain in the development of approaches to the prevention and management of type 1 diabetes and its complications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16530579     DOI: 10.1016/S0140-6736(06)68341-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  240 in total

1.  Environmental factors and primary prevention in type 1 diabetes.

Authors:  Jorma Ilonen; Outi Vaarala; Hans K Akerblom; Mikael Knip
Journal:  Pediatr Endocrinol Diabetes Metab       Date:  2009

Review 2.  The therapeutic potential of epigenetics in autoimmune diseases.

Authors:  Maria De Santis; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

3.  Up-regulation of fas and fasL pro-apoptotic genes expression in type 1 diabetes patients after autologous haematopoietic stem cell transplantation.

Authors:  G L V de Oliveira; K C R Malmegrim; A F Ferreira; R Tognon; S Kashima; C E B Couri; D T Covas; J C Voltarelli; F A de Castro
Journal:  Clin Exp Immunol       Date:  2012-06       Impact factor: 4.330

Review 4.  Microvascular disease in children and adolescents with type 1 diabetes and obesity.

Authors:  M Loredana Marcovecchio; Francesco Chiarelli
Journal:  Pediatr Nephrol       Date:  2010-08-19       Impact factor: 3.714

Review 5.  The incidence and prevalence of thyroid autoimmunity.

Authors:  Donald S A McLeod; David S Cooper
Journal:  Endocrine       Date:  2012-05-29       Impact factor: 3.633

Review 6.  Protein O-GlcNAcylation in diabetes and diabetic complications.

Authors:  Junfeng Ma; Gerald W Hart
Journal:  Expert Rev Proteomics       Date:  2013-08       Impact factor: 3.940

7.  Pharmaceutical care of adolescents with diabetes mellitus type 1: the DIADEMA study, a randomized controlled trial.

Authors:  Emina Obarcanin; Manfred Krüger; Petra Müller; Verena Nemitz; Holger Schwender; Snijezana Hasanbegovic; Sena Kalajdzisalihovic; Stephanie Läer
Journal:  Int J Clin Pharm       Date:  2015-04-28

Review 8.  Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases.

Authors:  Jinsha Liu; Joey Paolo Ting; Shams Al-Azzam; Yun Ding; Sepideh Afshar
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

9.  [Insulin therapy of diabetes].

Authors:  Monika Lechleitner; Michael Roden; Raimund Weitgasser; Bernhard Ludvik; Peter Fasching; Friedrich Hoppichler; Alexandra Kautzky-Willer; Guntram Schernthaner; Rudolf Prager; Thomas C Wascher
Journal:  Wien Klin Wochenschr       Date:  2012-12       Impact factor: 1.704

10.  Can Roux-en-Y gastric bypass provide a lifelong solution for diabetes mellitus?

Authors:  Abdulzahra Hussain; Hind Mahmood; Shamsi El-Hasani
Journal:  Can J Surg       Date:  2009-12       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.